Clinical Approach to Fever
Pediatric Comprehensive Framework1. Symptom Overview
Understanding the clinical significance and classification of fever in pediatric patients
Fever is the single most common chief complaint in pediatric emergency departments and outpatient clinics, accounting for approximately 20-30% of all pediatric visits. Children under 5 years of age average 4-6 febrile episodes per year, with the highest incidence occurring between 6 and 24 months of age. While the vast majority of pediatric fevers are self-limited viral illnesses, approximately 7-10% of febrile infants under 3 months of age will have a serious bacterial infection, making age-appropriate evaluation essential.
Definition
Fever is defined as an elevation in body temperature above the normal daily variation, resulting from a change in the hypothalamic thermoregulatory set point. In pediatrics, fever is generally defined as a rectal temperature of 38.0°C (100.4°F) or higher. Fever represents a regulated physiological response to infection or inflammation, distinct from hyperthermia, which is an unregulated rise in body temperature.
Key Epidemiology
- 20-30% of pediatric emergency visits are for fever
- 4-6 febrile episodes per year in children under 5 years
- 7-10% of febrile infants less than 3 months have serious bacterial infection
- Highest incidence: 6-24 months of age
- Peak fever prevalence: Winter and early spring (viral season)
Classification by Duration
| Category | Duration | Common Causes | Clinical Significance |
|---|---|---|---|
| Acute Fever | Less than 7 days | Viral upper respiratory infection, otitis media, gastroenteritis, urinary tract infection, pneumonia | Most common presentation; majority are self-limited viral infections; requires age-based risk stratification |
| Prolonged Fever | 7-14 days | Persistent viral infection (e.g., Epstein-Barr virus, cytomegalovirus), occult abscess, Kawasaki disease, drug fever | Requires broader differential consideration; higher likelihood of bacterial etiology or inflammatory condition |
| Fever of Unknown Origin | Greater than 14 days without identified source after initial workup | Infectious diseases (40-60%), connective tissue disorders (10-20%), malignancy (5-10%), miscellaneous (15-20%) | Requires systematic and comprehensive evaluation; specialist referral often indicated |
Temperature Measurement Methods
| Method | Age Recommendation | Fever Threshold | Accuracy Notes |
|---|---|---|---|
| Rectal | Gold standard for infants less than 3 months; acceptable for all ages | ≥38.0°C (100.4°F) | Most accurate reflection of core temperature; essential in young infants |
| Axillary | Screening method; less reliable | ≥37.5°C (99.5°F) | Underestimates core temperature by 0.5-1.0°C; confirm with rectal if elevated |
| Oral | Children 4 years and older who can cooperate | ≥37.8°C (100.0°F) | Affected by recent oral intake; requires closed mouth for 3-5 minutes |
| Tympanic | Children 6 months and older | ≥38.0°C (100.4°F) | User-dependent variability; affected by cerumen and ear anatomy |
| Temporal Artery | Children 3 months and older | ≥38.0°C (100.4°F) | Convenient but variable accuracy; affected by sweating and ambient temperature |
Classification by Pattern
Continuous Fever
Temperature remains elevated with fluctuations less than 1°C throughout the day. Does not return to normal baseline. Typical of typhoid fever, gram-negative pneumonia, and central nervous system infections.
Intermittent Fever
Temperature returns to normal at least once daily. Common in most pyogenic infections, abscesses, and infective endocarditis. The most frequent pattern seen in pediatric infections.
Remittent Fever
Temperature fluctuates more than 1°C during the day but does not return to normal. Seen in viral infections, bacterial infections, and infective endocarditis.
Relapsing/Periodic Fever
Fever episodes separated by days to weeks of normal temperature. Consider periodic fever syndromes (PFAPA, familial Mediterranean fever), malaria, or cyclic neutropenia.
Classification by Height of Fever
| Category | Temperature Range | Clinical Considerations |
|---|---|---|
| Low-grade Fever | 38.0-38.9°C (100.4-102.0°F) | Common with viral infections; height alone does not predict serious bacterial infection |
| Moderate Fever | 39.0-39.9°C (102.2-103.8°F) | Warrants closer evaluation; still commonly viral in well-appearing children |
| High Fever | ≥40.0°C (104.0°F) | Higher risk of bacteremia in children 3-36 months (approximately 4-5% if ≥40°C); requires careful assessment regardless of clinical appearance |
| Hyperpyrexia | ≥41.0°C (105.8°F) | Rare with infection alone; consider central nervous system pathology, drug reaction, or environmental hyperthermia |
Age-Based Risk Stratification
The approach to fever in pediatrics is fundamentally determined by age. Younger infants have immature immune systems, subtle clinical presentations, and higher rates of serious bacterial infection.
| Age Group | Risk of Serious Bacterial Infection | Key Concerns | General Approach |
|---|---|---|---|
| 0-28 days (Neonate) | 8-12% | Group B Streptococcus, Escherichia coli, Listeria monocytogenes, Herpes simplex virus; late-onset sepsis; poor localizing signs | Full sepsis workup; hospitalization and empiric antibiotics for all febrile neonates |
| 29-60 days | 5-10% | Urinary tract infection most common serious bacterial infection; meningitis risk still present; clinical appearance more reliable | Risk stratification using validated criteria (Rochester, Boston, Philadelphia, Step-by-Step); consider outpatient management for low-risk infants |
| 61-90 days | 3-5% | Urinary tract infection remains predominant; viral infections increasingly common; meningitis less common | Urinalysis essential; laboratory workup based on clinical appearance; outpatient management often appropriate |
| 3-36 months | 1-3% | Occult bacteremia (reduced with pneumococcal conjugate vaccine); urinary tract infection; pneumonia; meningitis (rare) | Clinical assessment paramount; targeted testing based on findings; antibiotics not routinely required for well-appearing children |
| Greater than 36 months | Less than 1% | Localizing signs typically present; viral infections predominate; serious bacterial infection uncommon in well-appearing children | Source-directed evaluation; testing guided by clinical findings |
Key Concept: The “Well-Appearing” Febrile Child
Clinical appearance is a powerful predictor of serious illness. A truly well-appearing child — one who is alert, interactive, consolable, has good color, and normal hydration — has a significantly lower risk of serious bacterial infection. However, this assessment is less reliable in infants under 3 months of age and does not exclude urinary tract infection at any age. The adage “fever without a source” should trigger systematic evaluation, especially in young infants, even when the child appears well.
2. Pathophysiology and Mechanisms
Understanding the underlying mechanisms of fever in children
Fever is a complex, coordinated physiological response that evolved as a host defense mechanism against infection. Understanding the mechanisms underlying fever helps clinicians appreciate why certain conditions cause fever, why fever patterns differ, and why antipyretic therapy, while providing symptomatic relief, does not address the underlying cause. The febrile response involves a cascade from peripheral detection of pathogens to central resetting of the hypothalamic thermostat.
Normal Thermoregulation
Body temperature is tightly regulated by the hypothalamic thermoregulatory center, located in the preoptic area of the anterior hypothalamus. This “thermostat” integrates input from peripheral and central thermoreceptors to maintain core temperature within a narrow range of approximately 36.5-37.5°C through a balance of heat production (metabolism, shivering, non-shivering thermogenesis) and heat dissipation (vasodilation, sweating, behavioral responses).
| Component | Structure/Location | Function |
|---|---|---|
| Peripheral Thermoreceptors | Skin, mucous membranes, deep tissues | Detect environmental temperature changes; transmit via spinothalamic tract to hypothalamus |
| Central Thermoreceptors | Preoptic area of anterior hypothalamus, spinal cord, abdominal viscera | Monitor core blood temperature; provide primary input for thermoregulatory adjustments |
| Thermoregulatory Center | Preoptic area and anterior hypothalamus | Integrates thermal information; sets the temperature “set point”; coordinates effector responses |
| Heat Production Effectors | Skeletal muscle (shivering), brown adipose tissue (non-shivering thermogenesis), metabolic pathways | Increase body temperature when below set point; brown fat particularly important in neonates |
| Heat Dissipation Effectors | Cutaneous blood vessels, sweat glands, respiratory system | Dissipate heat through vasodilation, sweating, and evaporative loss when above set point |
The Fever Cascade
Fever occurs when the hypothalamic set point is raised, typically in response to circulating pyrogens. This elevation causes the body to perceive its current temperature as “too cold,” triggering heat-generating mechanisms until the new, elevated set point is reached.
| Step | Process | Key Mediators |
|---|---|---|
| 1. Trigger Recognition | Pathogen-associated molecular patterns (PAMPs) or damage-associated molecular patterns (DAMPs) are recognized by pattern recognition receptors on immune cells | Toll-like receptors, NOD-like receptors, bacterial lipopolysaccharide, viral nucleic acids |
| 2. Exogenous Pyrogen Action | Exogenous pyrogens (microbial products) activate monocytes, macrophages, and other immune cells | Lipopolysaccharide (gram-negative), lipoteichoic acid (gram-positive), viral proteins |
| 3. Endogenous Pyrogen Release | Activated immune cells release endogenous pyrogens (pyrogenic cytokines) into circulation | Interleukin-1 (IL-1), Interleukin-6 (IL-6), Tumor Necrosis Factor-alpha (TNF-α), Interferon-gamma |
| 4. Central Signal Transduction | Cytokines reach the organum vasculosum of the lamina terminalis (OVLT) and stimulate local prostaglandin production | Prostaglandin E2 (PGE2) via cyclooxygenase-2 (COX-2) pathway |
| 5. Set Point Elevation | Prostaglandin E2 acts on EP3 receptors in the preoptic hypothalamus, raising the thermoregulatory set point | Prostaglandin E2, EP3 receptors, cyclic AMP |
| 6. Effector Response | Body perceives current temperature as too low; activates heat-generating mechanisms | Cutaneous vasoconstriction (chills, pallor), shivering, increased metabolic rate, behavioral changes (seeking warmth) |
Types of Pyrogens
Exogenous Pyrogens
Definition: Substances originating outside the body that initiate the febrile response
Sources:
- Bacterial products: lipopolysaccharide (gram-negative endotoxin), lipoteichoic acid, peptidoglycan, exotoxins
- Viral components: double-stranded RNA, viral coat proteins
- Fungal elements: beta-glucan, mannan
- Parasitic antigens
Clinical relevance: Direct correlation between pathogen load and fever severity in some infections
Endogenous Pyrogens
Definition: Host-derived cytokines that act centrally to produce fever
Key cytokines:
- Interleukin-1 (IL-1): Primary pyrogenic cytokine; multiple systemic effects
- Interleukin-6 (IL-6): Major inducer of acute phase response; correlates with fever height
- Tumor Necrosis Factor-alpha: Early response cytokine; synergistic effects with IL-1
- Interferon-gamma: Enhances macrophage activation; contributes to prolonged fever
Clinical relevance: Target for therapeutic intervention; elevated in autoinflammatory conditions
How Conditions Cause Fever in Children
| Condition Category | Mechanism | Clinical Implications |
|---|---|---|
| Bacterial Infections | Lipopolysaccharide (gram-negative) and lipoteichoic acid (gram-positive) activate Toll-like receptors on macrophages, triggering IL-1, IL-6, and TNF-alpha release; exotoxins from certain bacteria (e.g., toxic shock syndrome toxin) act as superantigens causing massive cytokine release | Often high fever with rigors; fever pattern may help identify source; gram-negative sepsis associated with rapid temperature fluctuations |
| Viral Infections | Viral nucleic acids (double-stranded RNA, CpG DNA) detected by intracellular pattern recognition receptors trigger interferon production and subsequent pyrogenic cytokine cascade; infected cells release DAMPs upon cell death | Self-limited fever lasting 3-5 days typical; respiratory viruses often cause biphasic fever; enterovirus may cause prolonged fever |
| Urinary Tract Infection | Bacterial invasion of urinary tract triggers local and systemic cytokine response; lipopolysaccharide from uropathogenic Escherichia coli particularly pyrogenic; pyelonephritis associated with higher fever than cystitis due to renal parenchymal involvement | Most common serious bacterial infection in febrile infants; fever may be only symptom in young children without localizing signs |
| Kawasaki Disease | Systemic vasculitis with intense activation of innate immune system; elevated IL-1, IL-6, and TNF-alpha; vascular endothelial activation; mechanism of initial trigger unknown but infectious agent suspected | Persistent high fever (≥5 days) unresponsive to antipyretics; early recognition critical to prevent coronary artery aneurysms |
| Juvenile Idiopathic Arthritis (Systemic) | Autoinflammatory process with overproduction of IL-1 and IL-6; activation of innate immune cells; macrophage activation syndrome may develop with massive cytokine storm | Characteristic quotidian fever pattern (daily high spikes returning to normal or subnormal); fever typically occurs with rash in late afternoon/evening |
| Periodic Fever Syndromes | Genetic mutations affecting inflammasome regulation (e.g., familial Mediterranean fever – pyrin mutation) or IL-1 pathway (e.g., CAPS – NLRP3 mutation); inappropriate activation of inflammatory cascade; PFAPA mechanism unclear but involves dysregulated tonsil immune response | Predictable recurrent fever episodes; PFAPA is most common periodic fever syndrome in children; dramatic response to corticosteroids suggests inflammatory mechanism |
| Malignancy | Tumor cells produce pyrogenic cytokines (IL-1, IL-6, TNF-alpha); necrotic tumor tissue releases DAMPs; tumor-associated infection; bone marrow involvement impairs immune function | Persistent unexplained fever; associated with night sweats, weight loss, lymphadenopathy; leukemia and lymphoma most common pediatric malignancies presenting with fever |
| Drug Fever | Various mechanisms including hypersensitivity reaction with cytokine release, direct pyrogenic effect, or altered thermoregulation; may involve hapten formation and immune complex deposition | Timing varies from days to weeks after starting medication; patient often appears “well for the degree of fever”; typically resolves within 48-72 hours of discontinuation |
| Vaccine-Related Fever | Immune response to vaccine antigens triggers controlled cytokine release; live attenuated vaccines may cause mild infection with viral replication; adjuvants enhance immune response and may contribute to fever | Expected response, not adverse reaction; timing varies by vaccine type (inactivated: 24-48 hours; live: 7-14 days); typically low-grade and brief |
Fever Versus Hyperthermia
Critical Distinction
Fever and hyperthermia are fundamentally different processes with different management approaches.
Fever (Pyrexia):
- Regulated elevation of set point
- Temperature rarely exceeds 41°C
- Antipyretics effective
- Part of host defense
- Example: infection, inflammation
Hyperthermia:
- Unregulated temperature rise; set point normal
- Can exceed 41°C and be life-threatening
- Antipyretics NOT effective
- Represents failure of thermoregulation
- Example: heat stroke, malignant hyperthermia, drug toxicity
Beneficial and Harmful Effects of Fever
Potential Benefits
- Enhanced immune function: Increased leukocyte mobility, phagocytosis, and bacterial killing
- Inhibited pathogen growth: Many bacteria and viruses replicate less efficiently at elevated temperatures
- Increased antibody production: Higher temperature enhances lymphocyte proliferation
- Enhanced interferon activity: Antiviral effects amplified at febrile temperatures
- Marker of disease: Helps identify illness and monitor response to treatment
Potential Harms
- Increased metabolic demand: 10-12% increase in metabolic rate per degree Celsius elevation
- Increased oxygen consumption: May stress cardiovascular system in children with cardiac disease
- Fluid losses: Increased insensible water loss; risk of dehydration
- Discomfort: Malaise, irritability, decreased oral intake
- Febrile seizures: Risk in predisposed children 6 months to 5 years (3-5% of children)
Often Overlooked: Brown Adipose Tissue and Neonatal Thermogenesis
Neonates cannot shiver effectively and rely heavily on non-shivering thermogenesis through brown adipose tissue (BAT). Located between the scapulae, around major vessels, and in the mediastinum, BAT generates heat through uncoupled oxidative phosphorylation. This mechanism is particularly active in the first weeks of life, making neonates more susceptible to both hypothermia (if BAT is depleted) and hyperthermia (if heavily bundled). Additionally, hypothermic neonates may not mount a febrile response to infection — temperature instability (including hypothermia) in a neonate is a red flag for sepsis and should be evaluated with the same urgency as fever.
Antipyretic Mechanism of Action
Understanding why antipyretics work helps reinforce the concept that fever is a prostaglandin-mediated process:
| Antipyretic | Mechanism | Clinical Notes |
|---|---|---|
| Acetaminophen (Paracetamol) | Inhibits central COX enzymes and prostaglandin E2 synthesis in hypothalamus; may also act on cannabinoid receptors; minimal peripheral anti-inflammatory effect | First-line antipyretic; safe dosing: 10-15 mg/kg every 4-6 hours (max 75 mg/kg/day); onset 30-60 minutes; duration 4-6 hours |
| Ibuprofen | Inhibits both COX-1 and COX-2 peripherally and centrally; blocks prostaglandin synthesis; also provides anti-inflammatory and analgesic effects | Alternative or adjunct; use in children ≥6 months; dosing: 5-10 mg/kg every 6-8 hours (max 40 mg/kg/day); longer duration of action than acetaminophen |
Key Concept: Antipyretics Treat Symptoms, Not Disease
Antipyretics lower temperature and improve comfort but do not treat the underlying cause of fever, do not prevent febrile seizures, and do not significantly alter the course of most infections. The goal of antipyretic therapy is to improve the child’s comfort and ability to maintain hydration and rest — not to normalize temperature. Response to antipyretics does not reliably distinguish serious bacterial infection from viral illness.
3. History Taking
A comprehensive approach to eliciting the fever history in pediatric patients
Red Flags — Require Urgent Evaluation
- Age less than 28 days — High risk of serious bacterial infection; requires full sepsis workup
- Ill or toxic appearance — Lethargy, poor perfusion, inconsolability suggest sepsis or meningitis
- Petechial or purpuric rash — Meningococcemia, other bacterial sepsis, or severe viral infection
- Bulging fontanelle — Meningitis or raised intracranial pressure
- Neck stiffness or photophobia — Meningitis (less reliable in infants)
- Seizure with fever — Complex febrile seizure or meningitis/encephalitis
- Respiratory distress — Pneumonia, bronchiolitis with impending respiratory failure, or sepsis
- Signs of dehydration — Poor intake, decreased urine output, sunken fontanelle, dry mucous membranes
- Immunocompromised state — Oncology patient, immunodeficiency, chronic steroid use
- Fever greater than 5 days — Kawasaki disease, occult abscess, or other serious infection
- No source identified in young infant — Urinary tract infection, occult bacteremia, or early meningitis
- Hyperpyrexia (≥41°C) — Consider central nervous system infection, drug reaction, or environmental cause
Systematic History: The “FEVERS” Approach
Use the mnemonic “FEVERS” to ensure comprehensive fever history taking in pediatric patients:
- F — Fever Characteristics: When did it start? How high? How measured? Pattern (continuous, intermittent, relapsing)? Response to antipyretics?
- E — Exposures and Environment: Sick contacts? Daycare/school attendance? Travel history? Animal exposure? Tick bites? Unimmunized contacts?
- V — Vaccination and Vital Background: Immunization status up to date? Birth history? Underlying medical conditions? Previous hospitalizations?
- E — Eating, Drinking, and Eliminating: Oral intake? Urine output (wet diapers)? Vomiting? Diarrhea? Last bowel movement?
- R — Review of Systems and Red Flags: Systematic symptom review? Rash? Respiratory symptoms? Neurological changes? Joint pain or swelling?
- S — Social and Safety: Who cares for the child? Medications at home (including access to adult medications)? Any concerns about safety or non-accidental injury?
Fever Characteristics
| Question | Why It Matters | Key Points |
|---|---|---|
| When did the fever start? | Duration guides differential and urgency | Fever greater than 5 days raises concern for Kawasaki disease; fever of unknown origin defined as greater than 14 days without source |
| How high has the temperature been? | Height of fever correlates with bacteremia risk in young children | Temperature ≥40°C in children 3-36 months associated with higher risk of serious bacterial infection; however, height alone does not exclude or confirm serious illness |
| How was temperature measured? | Rectal temperature is gold standard, especially in infants | In infants less than 3 months, rectal temperature required; parental report of fever (“felt warm”) should be taken seriously |
| What is the fever pattern? | Pattern may suggest specific diagnoses | Quotidian pattern (daily spikes) suggests systemic juvenile idiopathic arthritis; periodic fevers suggest autoinflammatory syndrome (PFAPA, familial Mediterranean fever) |
| Does fever respond to antipyretics? | Comfort measure; does NOT reliably distinguish viral from bacterial | Response to antipyretics improves comfort but does not exclude serious bacterial infection; Kawasaki disease fever classically does not respond well |
Targeted Questions by Suspected Cause
| Suspected Cause | Key Features | Ask This Question |
|---|---|---|
| Upper Respiratory Tract Infection | Rhinorrhea, cough, congestion, mild sore throat | “Does your child have a runny nose, cough, or congestion? Any sick contacts at daycare or school?” |
| Acute Otitis Media | Ear pain, ear tugging (infants), irritability, recent upper respiratory infection | “Has your child been pulling at their ears? Any fussiness, especially when lying down? Recent cold symptoms?” |
| Urinary Tract Infection | Dysuria, frequency, foul-smelling urine, abdominal pain; may be asymptomatic in infants | “Has your child complained of pain with urination? Any accidents after being toilet trained? Has the urine smelled different?” |
| Pneumonia | Cough, tachypnea, increased work of breathing, decreased oral intake | “Does your child have a cough? Are they breathing faster or harder than usual? Any chest pain or abdominal pain?” |
| Gastroenteritis | Vomiting, diarrhea, abdominal cramping, decreased oral intake | “Any vomiting or diarrhea? How many episodes? Any blood in the stool? Is your child keeping fluids down?” |
| Meningitis | Headache, neck stiffness, photophobia, altered mental status, irritability, bulging fontanelle | “Has your child complained of headache? Are they sensitive to light? More irritable or difficult to console? Any vomiting?” |
| Kawasaki Disease | Fever ≥5 days, rash, conjunctival injection, lip/oral changes, cervical lymphadenopathy, extremity changes | “Has the fever lasted more than 5 days? Any rash? Red eyes without discharge? Red or cracked lips? Swollen hands or feet? Swollen gland in the neck?” |
| Bone or Joint Infection | Limping, refusal to bear weight, focal bone tenderness, joint swelling | “Is your child limping or refusing to walk? Any swelling or tenderness over a bone or joint? Does moving a limb cause pain?” |
| Skin or Soft Tissue Infection | Localized redness, warmth, swelling, tenderness | “Have you noticed any areas of redness, swelling, or warmth on the skin? Any recent cuts, scrapes, or insect bites?” |
| Periodic Fever Syndrome (PFAPA) | Regular recurring episodes (every 3-6 weeks), aphthous ulcers, pharyngitis, adenitis | “Do fevers seem to occur on a regular schedule? During episodes, does your child get mouth sores, sore throat, or swollen glands?” |
Age-Specific History Components
Birth and Neonatal History (Essential for Infants)
| Component | Questions to Ask | Relevance to Fever |
|---|---|---|
| Gestational Age | Was the baby born premature? What was the gestational age at birth? | Premature infants have immature immune systems and higher risk of serious infection; chronic lung disease increases respiratory infection risk |
| Delivery and Complications | Vaginal or cesarean delivery? Prolonged rupture of membranes? Maternal Group B Streptococcus status? Maternal fever? | Risk factors for early-onset neonatal sepsis include prolonged rupture of membranes, maternal fever, and positive Group B Streptococcus colonization |
| NICU Stay | Did the baby require NICU admission? For how long? Any intubation or central lines? | NICU stay suggests prematurity or illness; previous invasive procedures may indicate anatomical abnormalities or chronic conditions |
| Newborn Screening | Were newborn screening results normal? | Abnormal screening may indicate immunodeficiency (severe combined immunodeficiency) or metabolic conditions predisposing to infection |
Immunization History
Critical Immunization Questions
- Is your child up to date on vaccinations? — Unimmunized or underimmunized children at higher risk for vaccine-preventable diseases (pertussis, Haemophilus influenzae type b, Streptococcus pneumoniae, measles)
- When was the last vaccine given? — Fever 24-48 hours after inactivated vaccines or 7-14 days after live vaccines (measles, mumps, rubella; varicella) may be vaccine-related
- Has your child received pneumococcal and Hib vaccines? — These vaccines dramatically reduce risk of invasive bacterial disease; unvaccinated children require more aggressive evaluation
- Any reactions to previous vaccines? — Important for determining safety of continued immunization
Feeding and Hydration History
| Age Group | Key Questions | Signs of Concern |
|---|---|---|
| Infants (0-12 months) | Breast or bottle feeding? How many feeds in last 24 hours? Duration of feeds? Any vomiting? How many wet diapers? | Refusing feeds, taking less than half usual volume, fewer than 4 wet diapers in 24 hours |
| Toddlers (1-3 years) | Drinking fluids? Eating solids? Any vomiting? Urine output? | Refusing all fluids, no urine output for 8+ hours, persistent vomiting |
| Older Children | Drinking fluids? Eating? Urinating normally? Any vomiting? | Unable to keep fluids down, significantly decreased urine output, very dark urine |
Exposure History
Infectious Exposures
- Sick contacts: Family members, daycare/school contacts with similar illness
- Daycare/school attendance: Higher exposure to respiratory and gastrointestinal pathogens
- Recent hospitalization: Healthcare-associated infections, resistant organisms
- Known outbreaks: Influenza, respiratory syncytial virus, pertussis, measles in community
Environmental Exposures
- Travel history: Endemic infections (malaria, dengue, typhoid, tuberculosis)
- Animal contacts: Cat scratch disease (cats), leptospirosis (rodents), psittacosis (birds)
- Tick exposure: Lyme disease, Rocky Mountain spotted fever, ehrlichiosis
- Water exposure: Recreational water, unchlorinated sources
Medication and Allergy History
Medications That May Cause Fever
- Antibiotics: Beta-lactams, sulfonamides, anticonvulsants (drug fever with rash — DRESS syndrome)
- Anticonvulsants: Phenytoin, carbamazepine, lamotrigine (drug reaction with eosinophilia)
- Recent vaccines: Expected response to immunization
- Anticholinergics: May impair heat dissipation (hyperthermia, not true fever)
- Chemotherapy: Neutropenic fever is a medical emergency
Important Medication Questions
- Current medications: Prescription, over-the-counter, herbal supplements
- Recent antibiotics: May mask developing serious infection or suggest resistant organism
- Antipyretic use: What given? Dose? Timing? Response?
- Chronic medications: Immunosuppressants, steroids increase infection risk
- Allergies: Important for treatment decisions
Review of Systems — Localizing the Source
| System | Symptoms to Ask About | Conditions to Consider |
|---|---|---|
| Head/ENT | Headache, ear pain, ear discharge, rhinorrhea, sore throat, mouth sores | Otitis media, sinusitis, pharyngitis, dental abscess, herpetic gingivostomatitis |
| Eyes | Red eyes, discharge, photophobia | Conjunctivitis, periorbital cellulitis, Kawasaki disease, measles |
| Respiratory | Cough, fast breathing, difficulty breathing, wheezing, chest pain | Upper respiratory infection, bronchiolitis, pneumonia, croup |
| Cardiovascular | Palpitations, chest pain, exercise intolerance, syncope | Myocarditis, pericarditis, endocarditis, Kawasaki disease |
| Gastrointestinal | Vomiting, diarrhea, abdominal pain, blood in stool, poor appetite | Gastroenteritis, appendicitis, intussusception, hepatitis |
| Genitourinary | Dysuria, frequency, urgency, foul-smelling urine, flank pain | Urinary tract infection, pyelonephritis |
| Musculoskeletal | Joint pain, joint swelling, limp, refusal to walk, bone pain | Septic arthritis, osteomyelitis, transient synovitis, juvenile idiopathic arthritis, malignancy |
| Skin | Rash, swelling, redness, warmth, wound | Viral exanthem, cellulitis, abscess, Kawasaki disease, scarlet fever, meningococcemia |
| Neurological | Headache, neck stiffness, confusion, irritability, seizures, weakness | Meningitis, encephalitis, brain abscess, febrile seizure |
| Lymphatic | Swollen glands, neck mass | Cervical lymphadenitis, Kawasaki disease, Epstein-Barr virus, malignancy |
Past Medical History and Family History
Past Medical History
- Previous serious infections: Recurrent serious bacterial infections suggest immunodeficiency
- Chronic conditions: Sickle cell disease (encapsulated organism risk), asthma, congenital heart disease, diabetes
- Previous surgeries: Splenectomy (infection risk), urological surgery (urinary tract infection risk), central lines
- Hospitalizations: Frequency, reasons, any intensive care admissions
- Immunodeficiency: Known primary immunodeficiency, HIV, malignancy, immunosuppressive therapy
Family History
- Immunodeficiency: Primary immunodeficiency disorders, early childhood deaths from infection
- Periodic fever syndromes: Familial Mediterranean fever, other autoinflammatory conditions
- Autoimmune conditions: Systemic lupus erythematosus, rheumatoid arthritis
- Consanguinity: Increased risk of autosomal recessive immunodeficiency
- Malignancy: Family history of childhood cancers
Clinical Pearl: The Caregiver’s Gut Feeling
Parents and caregivers know their children best. When a parent states that their child is “not acting right” or is “different from other times they’ve been sick,” take this seriously. Parental concern has been shown to be an independent predictor of serious illness in febrile children, even when objective parameters appear reassuring. Always ask: “Is there anything about this illness that worries you or seems different from other times your child has been sick?”
4. Physical Examination
A systematic head-to-toe approach for the febrile pediatric patient
Systematic Framework: Use the “Head to Extremities” approach for complete examination of the febrile child. The primary goals are to: (1) assess severity of illness, (2) identify a focus of infection, and (3) detect complications. Remember that in young infants, the examination may be normal despite serious bacterial infection.
Initial Assessment: Is This Child Sick?
Before the detailed examination, perform a rapid “across the room” assessment. The overall clinical appearance is the single most important factor in determining illness severity and guiding management urgency.
| Assessment Domain | Well-Appearing Child | Ill-Appearing Child |
|---|---|---|
| Alertness/Interaction | Alert, makes eye contact, interested in surroundings, responds to social cues | Lethargic, poor eye contact, disinterested, does not respond to social cues |
| Consolability | Cries but can be consoled by caregiver, settles when held | Inconsolable crying or weak/absent cry, does not settle with comfort measures |
| Color | Pink, normal skin color for ethnicity | Pale, mottled, gray, cyanotic |
| Respiratory Effort | Normal respiratory rate for age, no distress | Tachypnea, nasal flaring, grunting, retractions, accessory muscle use |
| Hydration | Moist mucous membranes, tears when crying, good skin turgor | Dry mucous membranes, no tears, prolonged capillary refill, sunken eyes/fontanelle |
| Activity | Age-appropriate activity, moves all extremities, explores environment | Limp, floppy, weak movements, does not resist examination |
The “Toxic” Child — Recognize Immediately
A toxic-appearing child requires immediate intervention regardless of temperature or identified source. Features include:
- Lethargy or altered mental status
- Poor perfusion (mottled skin, prolonged capillary refill greater than 3 seconds, cool extremities)
- Weak or absent cry
- Inconsolability
- Cyanosis or marked pallor
- Signs of respiratory failure (grunting, severe retractions, apnea)
Action: Immediate resuscitation, vascular access, empiric antibiotics, and urgent evaluation.
Vital Signs — Age-Specific Normal Values
Vital signs must be interpreted in the context of age. Fever itself causes tachycardia (heart rate increases approximately 10 beats per minute per degree Celsius elevation) and mild tachypnea.
| Age Group | Heart Rate (beats/min) | Respiratory Rate (/min) | Systolic Blood Pressure (mmHg) |
|---|---|---|---|
| Neonate (0-28 days) | 100-160 | 30-60 | 60-90 |
| Infant (1-12 months) | 100-150 | 25-40 | 80-100 |
| Toddler (1-3 years) | 90-140 | 20-30 | 90-105 |
| Preschool (3-5 years) | 80-120 | 20-25 | 95-110 |
| School Age (6-12 years) | 70-110 | 18-22 | 100-120 |
| Adolescent (13-18 years) | 60-100 | 12-20 | 110-130 |
| Vital Sign | What to Look For | Clinical Significance |
|---|---|---|
| Temperature | Height of fever; rectal preferred in infants less than 3 months; hypothermia in neonates | Temperature ≥40°C increases risk of bacteremia; hypothermia in neonates is a red flag for sepsis; hyperpyrexia ≥41°C suggests central nervous system pathology or environmental cause |
| Heart Rate | Tachycardia beyond what is expected for fever; bradycardia | Persistent tachycardia after defervescence suggests dehydration, pain, or ongoing serious illness; bradycardia may indicate raised intracranial pressure or impending cardiovascular collapse |
| Respiratory Rate | Tachypnea, particularly respiratory rate greater than 60 in infants or greater than 50 in young children | Tachypnea is sensitive (though not specific) for pneumonia; respiratory rate greater than 70 concerning for severe lower respiratory infection or metabolic acidosis |
| Blood Pressure | Hypotension (systolic less than 70 + [2 × age in years] for children 1-10 years) | Hypotension is a late sign of shock in children; do not wait for hypotension to recognize sepsis |
| Oxygen Saturation | SpO2 less than 94% on room air | Hypoxia indicates significant respiratory pathology; may occur with pneumonia, bronchiolitis, or sepsis; does not exclude pneumonia if normal |
| Capillary Refill Time | Prolonged refill greater than 2-3 seconds (press on sternum or fingernail) | Prolonged capillary refill indicates poor perfusion; concerning for sepsis, dehydration, or shock; central measurement (sternum) more reliable than peripheral |
General Inspection
- Level of consciousness: Alert versus lethargic versus obtunded; response to voice and stimulation
- Quality of cry: Strong and vigorous versus weak, high-pitched, or absent
- Interaction: Engages with caregiver and environment versus disinterested or unresponsive
- Position: Moving freely versus preferring one position (tripoding suggests respiratory distress; frog-leg position in infant suggests hypotonia)
- Color: Pink, pale, mottled, cyanotic, jaundiced
- Respiratory pattern: Easy breathing versus nasal flaring, grunting, retractions
- Nutrition/hydration: Well-nourished versus cachectic; signs of dehydration
- Rash: Any visible rash — distribution, type (macular, papular, vesicular, petechial, purpuric)
Growth Parameters
Plot weight, length/height, and head circumference (for children under 2 years) on appropriate growth charts. Weight loss may indicate acute dehydration; failure to thrive suggests chronic illness, immunodeficiency, or neglect.
Head, Eyes, Ears, Nose, and Throat Examination
Fontanelle (Infants)
- Normal: Soft, flat, pulsatile when infant is upright and calm
- Bulging: Meningitis, raised intracranial pressure (assess when calm, not crying)
- Sunken: Dehydration
- Anterior fontanelle: Closes by 12-18 months
Eyes
- Conjunctival injection: Viral conjunctivitis, Kawasaki disease (non-exudative, limbic-sparing), measles
- Periorbital swelling/erythema: Periorbital cellulitis (preseptal) versus orbital cellulitis (limited eye movements, proptosis, pain with movement)
- Sunken eyes: Dehydration
Ears
- Tympanic membrane: Bulging, erythematous, loss of light reflex, air-fluid level indicates acute otitis media
- External canal: Otitis externa causes pain with tragal pressure or pinna manipulation
- Mastoid tenderness: Mastoiditis (red flag — swelling and tenderness over mastoid process)
Nose and Throat
- Rhinorrhea: Clear (viral) versus purulent (bacterial sinusitis if prolonged)
- Pharynx: Erythema, tonsillar hypertrophy, exudate, palatal petechiae (Group A Streptococcus)
- Oral cavity: Vesicles (herpangina, hand-foot-mouth), ulcers (PFAPA, herpes), Koplik spots (measles), strawberry tongue (Kawasaki, scarlet fever)
- Lips: Cracked, erythematous (Kawasaki disease)
Neck Examination
- Nuchal rigidity: Resistance to passive neck flexion — meningitis (unreliable in infants less than 12-18 months)
- Kernig sign: Pain with knee extension when hip is flexed — meningeal irritation
- Brudzinski sign: Involuntary hip flexion when neck is passively flexed — meningeal irritation
- Lymphadenopathy: Location (cervical, submandibular, posterior), size, tenderness, mobility, overlying skin changes
- Torticollis: May indicate cervical lymphadenitis, retropharyngeal abscess, or meningitis
Respiratory Examination
Inspection
- Respiratory rate: Count for full 60 seconds; tachypnea is most sensitive sign of pneumonia
- Work of breathing: Nasal flaring, intercostal/subcostal/suprasternal retractions, head bobbing (infants), use of accessory muscles
- Grunting: Expiratory sound indicating attempt to maintain positive end-expiratory pressure — sign of significant lower respiratory disease
- Chest shape: Hyperinflation (bronchiolitis, asthma), asymmetry
Auscultation
| Finding | Description | Conditions |
|---|---|---|
| Crackles (rales) | Discontinuous, inspiratory sounds; fine (Velcro-like) or coarse | Pneumonia, bronchiolitis, pulmonary edema; fine crackles suggest alveolar involvement |
| Wheezes | Musical, continuous sounds; polyphonic (multiple airways) or monophonic (single airway) | Bronchiolitis, asthma, reactive airway disease; monophonic wheeze may indicate foreign body |
| Decreased breath sounds | Diminished air entry over lung field | Consolidation (pneumonia), pleural effusion, pneumothorax, mucus plugging |
| Bronchial breath sounds | Loud, tubular sounds heard over peripheral lung fields (normally heard only over trachea) | Consolidation — sound transmitted through solid lung tissue |
| Stridor | High-pitched inspiratory sound indicating upper airway obstruction | Croup, bacterial tracheitis, epiglottitis, foreign body, retropharyngeal abscess |
Percussion and Palpation
- Dullness to percussion: Consolidation, pleural effusion
- Hyperresonance: Pneumothorax, hyperinflation
- Tactile fremitus: Increased over consolidation, decreased over effusion
Cardiovascular Examination
- Heart rate and rhythm: Regular versus irregular; persistent tachycardia after defervescence concerning
- Heart sounds: Murmur (new murmur may indicate endocarditis or myocarditis), muffled heart sounds (pericardial effusion), gallop rhythm (heart failure)
- Peripheral perfusion: Capillary refill time, skin temperature (warm centrally but cool extremities suggests early compensated shock), color
- Pulses: Weak or thready pulses indicate poor cardiac output; bounding pulses may occur with high-output states
- Blood pressure: Hypotension is a late sign; wide pulse pressure may indicate sepsis
- Hepatomegaly: May indicate heart failure; palpate liver edge
Abdominal Examination
- Inspection: Distension, visible peristalsis, skin changes
- Auscultation: Bowel sounds (hyperactive with gastroenteritis, absent with ileus or peritonitis)
- Palpation: Tenderness (localized versus diffuse), guarding, rebound tenderness, masses
- Organomegaly: Hepatomegaly (infection, malignancy, heart failure), splenomegaly (Epstein-Barr virus, malaria, malignancy)
- Right lower quadrant tenderness: Appendicitis (may be difficult to assess in young children; observe for guarding)
- Suprapubic tenderness: Urinary tract infection, bladder distension
- Costovertebral angle tenderness: Pyelonephritis (flank pain)
Skin Examination
Examine the entire skin surface, including mucous membranes, palms, soles, and diaper area. Rash characteristics help identify etiology.
| Rash Type | Description | Conditions |
|---|---|---|
| Maculopapular | Flat (macules) and raised (papules) lesions; often starts on face/trunk and spreads | Viral exanthems (measles, rubella, roseola, enterovirus), drug reaction, Kawasaki disease |
| Vesicular | Small fluid-filled blisters | Varicella (chickenpox), herpes simplex, hand-foot-mouth disease, impetigo |
| Petechial | Pinpoint, non-blanching red spots (less than 2 mm) | Meningococcemia (rapidly progressive), viral infection, thrombocytopenia, endocarditis |
| Purpuric | Larger non-blanching areas (greater than 2 mm) | Meningococcemia, Henoch-Schönlein purpura, disseminated intravascular coagulation |
| Erythroderma | Diffuse, sandpaper-like erythema | Scarlet fever (Group A Streptococcus), toxic shock syndrome, Kawasaki disease |
| Urticarial | Raised, pruritic wheals that migrate | Allergic reaction, viral infection, serum sickness-like reaction |
| Cellulitis | Localized erythema, warmth, swelling, tenderness | Bacterial skin infection (Group A Streptococcus, Staphylococcus aureus) |
Petechiae and Purpura — Do Not Miss
Non-blanching rash in a febrile child requires urgent evaluation. While petechiae can occur with benign conditions (coughing, vomiting, tourniquet effect), petechiae below the nipple line in a febrile child should be considered meningococcemia until proven otherwise. Rapidly spreading petechiae or purpura with ill appearance is a medical emergency requiring immediate antibiotics and resuscitation.
Musculoskeletal Examination
- Observation: Gait (limping, refusal to walk), spontaneous movement of limbs, posture, joint swelling
- Palpation: Bone tenderness (osteomyelitis — point tenderness over metaphysis), joint warmth and effusion (septic arthritis)
- Range of motion: Pain with passive movement suggests septic arthritis or osteomyelitis; pseudoparalysis (refusal to move limb) in infant may indicate bone or joint infection
- Hip examination: Septic arthritis of hip is an orthopedic emergency; infant holds hip flexed and externally rotated; limited internal rotation and pain with log roll
Neurological Examination
- Mental status: Level of alertness, interaction, response to stimulation
- Fontanelle: Bulging (increased intracranial pressure, meningitis), sunken (dehydration)
- Tone: Hypotonia (sepsis, meningitis), hypertonia (meningitis, tetanus)
- Reflexes: Age-appropriate primitive reflexes in infants; deep tendon reflexes
- Focal deficits: Asymmetric movements, cranial nerve abnormalities (brain abscess, encephalitis)
- Meningeal signs: Nuchal rigidity, Kernig, Brudzinski (unreliable in infants)
Extremities — Kawasaki Disease Features
- Hands and feet: Erythema of palms and soles, firm edema of dorsum of hands/feet (acute phase)
- Periungual desquamation: Peeling skin around nails (subacute phase, 10-14 days after fever onset)
- Peripheral edema: Non-pitting edema of hands and feet
Expected Examination Findings by Etiology
| Condition | General Appearance | Key Examination Findings | What May Be Normal |
|---|---|---|---|
| Viral Upper Respiratory Infection | Well-appearing, interactive | Rhinorrhea, mild pharyngeal erythema, mildly injected tympanic membranes | Lungs clear, normal work of breathing |
| Acute Otitis Media | Fussy but consolable, may tug at ear | Bulging, erythematous tympanic membrane with loss of landmarks; may have otorrhea if perforated | Remainder of examination may be normal |
| Pneumonia | Tachypnea, may be in distress | Tachypnea, crackles, decreased breath sounds, increased work of breathing; may have abdominal pain (referred from lower lobe) | Chest examination may be normal in early pneumonia |
| Urinary Tract Infection | Often well-appearing; may be fussy in infants | Suprapubic tenderness, costovertebral angle tenderness (pyelonephritis) | Examination frequently normal, especially in young children |
| Meningitis | Ill or toxic, irritable, lethargic | Bulging fontanelle (infant), nuchal rigidity, photophobia, Kernig/Brudzinski signs, petechial rash | Meningeal signs often absent in infants less than 12-18 months |
| Kawasaki Disease | Irritable, uncomfortable despite treatment | Bilateral non-exudative conjunctivitis, polymorphous rash, oral changes (strawberry tongue, cracked lips), cervical lymphadenopathy (≥1.5 cm), extremity changes | Not all criteria present initially; may be incomplete presentation |
| Septic Arthritis | Uncomfortable, refuses to move affected limb | Joint swelling, warmth, erythema; extremely painful with passive range of motion; pseudoparalysis in infant | May have minimal external findings with hip involvement |
| Occult Bacteremia | Often well-appearing with high fever | May have no localizing findings | Examination often completely normal |
Important Teaching Point: Normal Examination Does Not Exclude Serious Illness
In febrile infants, particularly those under 3 months of age, the physical examination may be completely normal despite the presence of serious bacterial infection. Urinary tract infection, occult bacteremia, and early meningitis may present with fever alone. This is why age-based risk stratification and appropriate laboratory evaluation are essential in young febrile infants, regardless of clinical appearance. Never assume a well-appearing young infant with fever is “fine” without appropriate workup.
Clinical Pearl: The “Fever-Free Window”
Reassess the child during a period when antipyretics have reduced the fever (the “fever-free window”). A child who looks significantly better when afebrile is more reassuring than one who remains lethargic or ill-appearing despite temperature normalization. However, this assessment is less reliable in infants under 3 months and does not exclude urinary tract infection or occult bacteremia at any age. The fever-free window is a useful adjunct but should not be the sole determinant of management.
5. Differential Diagnosis
Systematic approach organized by probability, age, and clinical features
The differential diagnosis of fever in pediatric patients is broad and must be approached systematically. Age is the most critical factor in determining both the likelihood of serious bacterial infection and the probable pathogens. This section organizes causes by probability, duration, age group, and anatomical location to facilitate clinical reasoning.
Key Principle: Age-Based Risk Stratification
The approach to fever fundamentally changes based on age:
- 0-28 days: High risk (8-12% serious bacterial infection) — full sepsis workup for all
- 29-60 days: Moderate risk (5-10%) — risk stratification using validated criteria
- 61-90 days: Lower risk (3-5%) — clinical assessment guides workup
- 3-36 months: Low risk (1-3%) — clinical appearance paramount; targeted testing
- >36 months: Very low risk (<1%) — source-directed evaluation
Acute Fever (Duration Less Than 7 Days)
| Probability | Condition | Key Features | Red Flags |
|---|---|---|---|
| COMMON (~80%) | Viral Upper Respiratory Tract Infection | Rhinorrhea, cough, mild sore throat, low-grade fever; self-limited 3-5 days | Severe respiratory distress, toxic appearance |
| Acute Otitis Media | Ear pain, ear tugging, irritability; often follows upper respiratory infection | Mastoid tenderness, facial nerve palsy | |
| Viral Gastroenteritis | Vomiting, diarrhea, abdominal cramping; fever usually low-grade | Bloody diarrhea, severe dehydration, bilious vomiting | |
| Pharyngitis/Tonsillitis | Sore throat, dysphagia; viral (most common) or bacterial (Group A Streptococcus) | Drooling, trismus, uvular deviation, respiratory distress | |
| Viral Exanthem | Fever with characteristic rash; roseola, enterovirus, adenovirus | Petechial/purpuric rash, toxic appearance | |
| Bronchiolitis | Wheezing, tachypnea, respiratory distress in infant less than 2 years; respiratory syncytial virus most common | Apnea, cyanosis, severe respiratory distress | |
| LESS COMMON (~15%) | Urinary Tract Infection | May be sole cause of fever without localizing signs in young children; dysuria, frequency in older children | Pyelonephritis signs (flank pain, high fever, ill appearance) |
| Pneumonia | Cough, tachypnea, increased work of breathing; may present with abdominal pain | Hypoxia, severe respiratory distress, toxic appearance | |
| Influenza | Abrupt onset high fever, myalgia, headache, cough; seasonal pattern | Altered mental status, seizures, severe respiratory symptoms | |
| Croup (Laryngotracheobronchitis) | Barking cough, stridor, hoarseness; typically 6 months to 3 years | Stridor at rest, severe respiratory distress, drooling | |
| Skin/Soft Tissue Infection | Localized erythema, warmth, swelling; cellulitis, abscess, impetigo | Rapidly spreading erythema, crepitus, systemic toxicity | |
| UNCOMMON BUT SERIOUS (~5%) | Bacterial Meningitis | Headache, neck stiffness, photophobia, altered mental status; bulging fontanelle in infants | All cases are emergencies — rapid progression, seizures, petechial rash |
| Bacteremia/Sepsis | High fever without source; toxic appearance; may be occult in young infants | Toxic appearance, poor perfusion, hypotension | |
| Septic Arthritis/Osteomyelitis | Limp, refusal to bear weight, focal bone/joint tenderness, pseudoparalysis in infant | Hip involvement (orthopedic emergency), systemic toxicity | |
| Appendicitis | Periumbilical pain migrating to right lower quadrant, anorexia, vomiting | Perforation signs (rigid abdomen, rebound, high fever) | |
| Bacterial Tracheitis | Toxic child with croup-like symptoms not responding to standard therapy | High fever, toxic appearance, purulent secretions | |
| Herpes Simplex Virus (Neonates) | Fever, irritability, seizures, vesicular rash in neonate; may be disseminated | All neonatal herpes simplex virus is serious — encephalitis, disseminated disease |
Prolonged Fever (7-14 Days) and Fever of Unknown Origin (>14 Days)
Step-by-Step Approach to Prolonged/Persistent Fever:
- Step 1: Confirm true fever — Document temperature objectively; rule out factitious fever
- Step 2: Review for missed common causes — Urinary tract infection, sinusitis, occult abscess, drug fever
- Step 3: Consider Kawasaki disease — Fever ≥5 days with other features; do not wait for all criteria
- Step 4: Evaluate for serious bacterial infections — Endocarditis, osteomyelitis, deep abscess
- Step 5: Consider inflammatory and autoimmune conditions — Juvenile idiopathic arthritis, inflammatory bowel disease
- Step 6: Evaluate for malignancy — Leukemia, lymphoma, neuroblastoma
| Category | Condition | Approximate Frequency in Fever of Unknown Origin | Key Distinguishing Features |
|---|---|---|---|
| INFECTIOUS (40-60%) | Epstein-Barr Virus (Infectious Mononucleosis) | Common | Fatigue, pharyngitis, lymphadenopathy, splenomegaly; atypical lymphocytes on blood smear |
| Cytomegalovirus | Common | Mononucleosis-like syndrome; less pharyngitis than Epstein-Barr virus; hepatosplenomegaly | |
| Occult Abscess | Less common | Intra-abdominal, pelvic, dental, hepatic; may have localized tenderness or be clinically silent | |
| Tuberculosis | Varies by prevalence | Cough, weight loss, night sweats, lymphadenopathy; contact history; endemic exposure | |
| Infective Endocarditis | Rare but serious | Predisposing heart lesion, new murmur, splenomegaly, splinter hemorrhages, embolic phenomena | |
| INFLAMMATORY/ AUTOIMMUNE (10-20%) | Kawasaki Disease | Common in young children | Fever ≥5 days, rash, conjunctivitis, oral changes, lymphadenopathy, extremity changes; may be incomplete |
| Systemic Juvenile Idiopathic Arthritis | Less common | Quotidian fever (daily spikes), evanescent salmon-colored rash, arthritis, hepatosplenomegaly | |
| Inflammatory Bowel Disease | Less common | Abdominal pain, diarrhea (may be bloody), weight loss, growth failure, perianal disease | |
| Systemic Lupus Erythematosus | Rare in young children | Multisystem involvement, malar rash, arthritis, nephritis, cytopenias; more common in adolescent females | |
| MALIGNANCY (5-10%) | Leukemia | Most common pediatric malignancy with fever | Pallor, fatigue, bruising, bone pain, hepatosplenomegaly, lymphadenopathy; cytopenias on complete blood count |
| Lymphoma | Less common | Lymphadenopathy (often cervical or mediastinal), night sweats, weight loss, pruritus | |
| Neuroblastoma | Rare | Abdominal mass, periorbital ecchymoses (“raccoon eyes”), opsoclonus-myoclonus syndrome | |
| MISCELLANEOUS (15-20%) | Drug Fever | Variable | Temporal relationship to medication; patient often appears “well for degree of fever”; may have rash |
| Periodic Fever Syndromes | Rare but increasingly recognized | Regular recurring episodes; PFAPA most common — aphthous ulcers, pharyngitis, adenitis; response to corticosteroids | |
| Factitious Fever | Rare | Discrepancy between temperature and clinical appearance; consider in adolescents or with Munchausen by proxy |
Age-Based Differential Diagnosis
The most likely causes of fever vary significantly by age group due to differences in immune maturity, pathogen exposure, and anatomical factors.
| Age Group | Common Causes | Serious Bacterial Infections to Consider | Special Considerations |
|---|---|---|---|
| Neonate (0-28 days) | Group B Streptococcus, Escherichia coli, Listeria monocytogenes, Herpes simplex virus, enteroviruses | Bacteremia, meningitis, urinary tract infection, pneumonia, herpes simplex virus disseminated/CNS disease | Maternal history critical (Group B Streptococcus status, herpes simplex virus, rupture of membranes); hypothermia may indicate sepsis; always requires full workup |
| Young Infant (29-90 days) | Respiratory viruses, urinary tract infection (Escherichia coli), Group B Streptococcus (late-onset), Streptococcus pneumoniae | Urinary tract infection (most common), bacteremia, meningitis | Risk stratification criteria applicable; urinary tract infection may be only serious bacterial infection in well-appearing infant; viral testing helps risk stratification |
| Infant (3-12 months) | Viral upper respiratory infection, otitis media, roseola, bronchiolitis, gastroenteritis | Urinary tract infection, occult bacteremia (reduced with vaccines), pneumonia | Immunization status critical; post-pneumococcal conjugate vaccine era has dramatically reduced bacteremia; urinary tract infection remains important |
| Toddler (1-3 years) | Viral infections, otitis media, pharyngitis, viral exanthems, croup | Urinary tract infection, pneumonia, septic arthritis/osteomyelitis, Kawasaki disease | Peak age for Kawasaki disease; febrile seizures most common in this age group; verbal toddlers may localize symptoms |
| Preschool (3-5 years) | Viral upper respiratory infection, pharyngitis (including Group A Streptococcus), otitis media, pneumonia | Pneumonia, urinary tract infection, appendicitis (uncommon but possible) | Group A Streptococcus pharyngitis becomes more common; can often describe symptoms; daycare/school exposures |
| School Age (6-12 years) | Viral infections, Group A Streptococcus pharyngitis, pneumonia, influenza, sinusitis | Pneumonia, appendicitis, bone/joint infections, urinary tract infection | Can reliably report symptoms; fever of unknown origin workup similar to adults; consider infectious mononucleosis |
| Adolescent (13-18 years) | Viral infections, infectious mononucleosis, influenza, pharyngitis | Appendicitis, pelvic inflammatory disease, tubo-ovarian abscess, septic arthritis | Consider sexually transmitted infections and pregnancy-related complications; similar approach to adult differential |
Anatomical Approach to Fever Source
Head and Neck
Otitis media
Pharyngitis/Tonsillitis
Sinusitis
Peritonsillar abscess
Retropharyngeal abscess
Cervical lymphadenitis
Dental abscess
Mastoiditis
Meningitis/Encephalitis
Respiratory
Viral upper respiratory infection
Croup
Bronchiolitis
Pneumonia
Bacterial tracheitis
Epiglottitis (rare with vaccination)
Empyema
Lung abscess
Abdominal/Pelvic
Gastroenteritis
Appendicitis
Urinary tract infection
Pyelonephritis
Hepatitis
Intra-abdominal abscess
Pelvic inflammatory disease (adolescents)
Intussusception
Musculoskeletal/Skin
Cellulitis
Abscess
Septic arthritis
Osteomyelitis
Pyomyositis
Necrotizing fasciitis
Reactive arthritis
Viral exanthem
Drug-Induced Fever in Children
| Drug or Drug Class | Mechanism | Characteristics | Time to Resolution After Stopping |
|---|---|---|---|
| Beta-lactam Antibiotics | Hypersensitivity reaction; immune complex formation | Fever with or without rash; patient often appears well; may occur after several days of therapy | 24-72 hours |
| Sulfonamides (Trimethoprim-Sulfamethoxazole) | Hypersensitivity reaction | Fever, rash (may be severe — Stevens-Johnson syndrome risk); eosinophilia | 48-72 hours; longer if severe reaction |
| Anticonvulsants (Phenytoin, Carbamazepine, Lamotrigine) | Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome) | Fever, rash, lymphadenopathy, hepatitis, eosinophilia; onset 2-6 weeks after starting | Days to weeks; may require systemic corticosteroids |
| Vaccines | Expected immune response to antigen | Low-grade fever; inactivated vaccines: 24-48 hours; live vaccines (measles, mumps, rubella; varicella): 7-14 days post-vaccination | Self-limited; 1-2 days |
| Atropine/Anticholinergics | Impaired heat dissipation (hyperthermia, not true fever) | Dry skin, flushing, mydriasis, tachycardia, altered mental status | Hours to 1-2 days depending on drug half-life |
| Chemotherapy | Neutropenia with infection; tumor lysis; drug reaction | Neutropenic fever is a medical emergency; requires immediate evaluation and empiric antibiotics | Depends on cause; neutropenic fever requires treatment, not drug cessation |
| Amphotericin B | Direct pyrogenic effect; cytokine release | Fever, rigors during or shortly after infusion; common and expected | Hours after infusion; premedication can reduce |
Periodic Fever Syndromes
Consider in children with recurrent, predictable fever episodes separated by symptom-free intervals.
| Syndrome | Inheritance/Gene | Episode Frequency | Key Features | Treatment |
|---|---|---|---|---|
| PFAPA (Periodic Fever, Aphthous Stomatitis, Pharyngitis, Adenitis) | Non-hereditary (most common periodic fever syndrome) | Every 3-6 weeks; clockwork regularity | High fever 3-6 days, aphthous ulcers, pharyngitis, cervical adenitis; well between episodes; normal growth | Single dose of corticosteroid aborts episode; tonsillectomy often curative |
| Familial Mediterranean Fever | Autosomal recessive; MEFV gene | Variable; days to weeks apart | Fever 1-3 days, serositis (peritonitis, pleuritis), arthritis, erysipelas-like rash; Mediterranean/Middle Eastern ancestry | Colchicine (prevents episodes and amyloidosis) |
| Hyper-IgD Syndrome (Mevalonate Kinase Deficiency) | Autosomal recessive; MVK gene | Every 4-8 weeks | Fever 3-7 days, cervical lymphadenopathy, abdominal pain, diarrhea, arthralgia, rash; elevated IgD | IL-1 inhibitors; corticosteroids |
| TRAPS (TNF Receptor-Associated Periodic Syndrome) | Autosomal dominant; TNFRSF1A gene | Variable; episodes last longer (1-3 weeks) | Prolonged fever episodes, migratory myalgia, periorbital edema, conjunctivitis, abdominal pain | IL-1 inhibitors; corticosteroids |
Quick Reference: “If You See This, Think This First”
| Clinical Clue | Think This First | Next Step |
|---|---|---|
| Fever in neonate (0-28 days) | Serious bacterial infection until proven otherwise | Full sepsis workup; admit and treat empirically |
| Fever ≥5 days in child less than 5 years | Kawasaki disease | Evaluate for Kawasaki criteria; echocardiogram; do not delay treatment waiting for all criteria |
| Petechial/purpuric rash with fever | Meningococcemia | Immediate antibiotics (do not delay for testing); resuscitation; lumbar puncture if stable |
| Fever with limp or refusal to bear weight | Septic arthritis or osteomyelitis | Urgent orthopedic consultation; imaging; joint aspiration if effusion present |
| Fever with bulging fontanelle in infant | Bacterial meningitis | Lumbar puncture; empiric antibiotics immediately |
| Toxic-appearing febrile child | Sepsis/Bacteremia | Immediate resuscitation; vascular access; cultures; empiric broad-spectrum antibiotics |
| Fever without source in infant 29-90 days | Urinary tract infection (most common serious bacterial infection) | Urinalysis and culture (catheterized specimen); risk stratify using validated criteria |
| Fever with quotidian pattern and rash | Systemic juvenile idiopathic arthritis | Rheumatology referral; evaluate for macrophage activation syndrome |
| Recurrent predictable fevers every 3-6 weeks | PFAPA syndrome | Trial of single-dose corticosteroid; ENT referral for tonsillectomy consideration |
| Fever with pallor, bruising, bone pain | Leukemia | Complete blood count with differential; peripheral blood smear; urgent hematology/oncology referral |
| Fever with severe sore throat and drooling | Peritonsillar abscess or retropharyngeal abscess | ENT consultation; CT with contrast; do not examine throat if epiglottitis suspected |
| Fever in immunocompromised/oncology patient | Neutropenic fever emergency | Immediate broad-spectrum antibiotics within 60 minutes; cultures; contact oncology |
Clinical Pearl: The Unimmunized or Underimmunized Child
The differential diagnosis and approach change significantly for unimmunized or underimmunized children. Before widespread vaccination, Haemophilus influenzae type b and Streptococcus pneumoniae were common causes of invasive disease including meningitis, epiglottitis, and bacteremia. In unvaccinated children, these organisms must be considered more prominently, and a more aggressive evaluation approach is warranted. Always check immunization status early in the evaluation of any febrile child.
6. Diagnostic Investigations
Age-stratified, cost-effective approach guided by clinical suspicion
The approach to investigating fever in children is fundamentally guided by age, clinical appearance, and the presence or absence of a source. Unlike adults, where fever alone rarely prompts extensive testing, young infants require systematic evaluation due to their high risk of serious bacterial infection and unreliable clinical signs. This section outlines age-appropriate investigation strategies.
Critical Principle: Age Determines Workup Intensity
The younger the child, the more comprehensive the evaluation required:
- 0-28 days: Full sepsis workup for ALL febrile neonates — no exceptions
- 29-60 days: Risk stratification; laboratory testing in most; lumbar puncture based on criteria
- 61-90 days: Urinalysis essential; further testing based on clinical assessment
- >90 days: Source-directed evaluation; testing guided by clinical findings
Febrile Neonate (0-28 Days): Full Sepsis Workup
All febrile neonates require complete evaluation regardless of clinical appearance. Neonates have immature immune systems, cannot localize infection, and may deteriorate rapidly.
| Investigation | Purpose | Key Values/Findings | Clinical Notes |
|---|---|---|---|
| Complete Blood Count with Differential | Assess for leukocytosis, leukopenia, bandemia, thrombocytopenia | White blood cell count <5,000 or >15,000/μL concerning; bands >10%; platelet count <150,000 | Normal complete blood count does not exclude serious bacterial infection in neonates; bandemia and leukopenia particularly concerning |
| Blood Culture | Identify bacteremia | Positive growth of pathogen | Obtain before antibiotics if possible; do not delay treatment; adequate volume critical (minimum 1 mL) |
| Urinalysis and Urine Culture | Identify urinary tract infection | Positive leukocyte esterase, nitrites, pyuria (>10 WBC/hpf); culture >50,000 CFU/mL single organism (catheterized) | Must obtain via catheterization or suprapubic aspiration; bag specimens unacceptable for culture |
| Lumbar Puncture with Cerebrospinal Fluid Studies | Evaluate for meningitis | Normal cerebrospinal fluid: WBC <20-30/μL (neonates may have higher normal values); protein <150 mg/dL; glucose >40 mg/dL or >50% serum glucose | Mandatory in febrile neonates; includes cell count, protein, glucose, Gram stain, culture; consider herpes simplex virus polymerase chain reaction |
| Herpes Simplex Virus Polymerase Chain Reaction (Cerebrospinal Fluid and Surface Cultures) | Identify neonatal herpes simplex virus infection | Positive polymerase chain reaction in cerebrospinal fluid, blood, or surface sites | Obtain if any risk factors (maternal herpes simplex virus history, vesicles, seizures, elevated liver enzymes); surface cultures from conjunctiva, mouth, nasopharynx, rectum |
| Chest Radiograph | Evaluate for pneumonia | Infiltrate, consolidation, effusion | Obtain if any respiratory symptoms; may be obtained routinely in full sepsis workup |
| C-Reactive Protein / Procalcitonin | Inflammatory markers to assist risk stratification | C-reactive protein >20 mg/L or procalcitonin >0.5 ng/mL suggests bacterial infection | Increasingly used in risk stratification; procalcitonin may be more specific for bacterial infection |
Febrile Infant 29-60 Days: Risk Stratification Approach
Several validated criteria exist to identify low-risk infants who may be managed as outpatients. High-risk infants require full evaluation and empiric antibiotics.
| Criteria | Low-Risk Definition | If Low-Risk | If High-Risk |
|---|---|---|---|
| Rochester Criteria | Well-appearing; no focal bacterial infection; WBC 5,000-15,000/μL; bands <1,500/μL; urinalysis <10 WBC/hpf; stool <5 WBC/hpf (if diarrhea) | Serious bacterial infection risk ~1%; consider outpatient management with close follow-up | Full workup including lumbar puncture; admit for empiric antibiotics |
| Step-by-Step Approach | Includes procalcitonin <0.5 ng/mL; C-reactive protein <20 mg/L; absolute neutrophil count <10,000/μL; negative urinalysis | Very low risk of serious bacterial infection; outpatient observation may be appropriate | Full workup; admission; empiric antibiotics |
Standard Investigation Panel for Febrile Infant 29-60 Days:
- Complete blood count with differential
- Blood culture
- Urinalysis and urine culture (catheterized specimen)
- C-reactive protein and/or procalcitonin
- Lumbar puncture with cerebrospinal fluid studies (if ill-appearing or high-risk criteria met)
- Respiratory viral panel (if respiratory symptoms — helps with risk stratification)
- Chest radiograph (if respiratory symptoms present)
Febrile Infant 61-90 Days
Clinical appearance becomes more reliable in this age group. Well-appearing infants with clear viral syndrome may require limited testing.
| Investigation | When to Obtain | Clinical Rationale |
|---|---|---|
| Urinalysis and Urine Culture | All febrile infants in this age group without clear source | Urinary tract infection remains most common serious bacterial infection; may be only finding in otherwise well infant |
| Complete Blood Count | No clear source; ill appearance; temperature ≥39°C | White blood cell count >15,000/μL or elevated inflammatory markers increase suspicion for bacterial infection |
| Blood Culture | If obtaining complete blood count; ill-appearing; high fever without source | Risk of bacteremia lower than younger infants but still present |
| Lumbar Puncture | Ill-appearing; meningeal signs; altered mental status; high clinical suspicion | Not routinely required in well-appearing infant with identified source; threshold lower than older children |
| Inflammatory Markers (C-Reactive Protein/Procalcitonin) | No clear source; to assist in risk stratification | Normal values reassuring; elevated values prompt broader workup |
Febrile Child 3-36 Months
Clinical assessment is paramount in this age group. The well-appearing child with clear viral source requires minimal testing. Fever without source warrants targeted evaluation.
| Investigation | When to Obtain | Clinical Notes |
|---|---|---|
| Urinalysis and Urine Culture | Fever without source; girls <24 months; uncircumcised boys <12 months; circumcised boys <6 months; any child with urinary symptoms | Catheterized specimen for culture in non-toilet-trained; clean catch acceptable in toilet-trained children |
| Complete Blood Count | Ill appearance; temperature ≥39°C without source; prolonged fever | Helps identify occult bacteremia risk; evaluate for leukemia if cytopenias or blasts |
| Blood Culture | Ill appearance; temperature ≥39°C without source; before starting antibiotics | Risk of occult bacteremia is low (<1%) in fully immunized, well-appearing children post-pneumococcal conjugate vaccine era |
| Chest Radiograph | Respiratory symptoms; tachypnea; hypoxia; crackles on examination | Not required in well-appearing child with upper respiratory symptoms and normal examination; tachypnea is most sensitive sign for pneumonia |
| Rapid Strep Test/Throat Culture | Pharyngitis symptoms in children ≥3 years | Group A Streptococcus rare under age 3; testing not routinely recommended in young toddlers |
| Lumbar Puncture | Ill appearance; meningeal signs; altered mental status; complex febrile seizure | Not routinely required in well-appearing child with simple febrile seizure |
Febrile Child Greater Than 36 Months
Source-directed evaluation based on clinical findings. Most febrile children in this age group have self-limited viral illness and require no testing.
| Investigation | When to Obtain | Clinical Notes |
|---|---|---|
| Rapid Strep Test/Throat Culture | Pharyngitis with features suggestive of Group A Streptococcus (exudate, tender anterior cervical nodes, fever, absence of cough) | Use clinical prediction rules (Centor/McIsaac criteria); backup culture if rapid test negative |
| Chest Radiograph | Clinical suspicion for pneumonia (cough, tachypnea, decreased breath sounds, hypoxia) | Not needed for typical upper respiratory infection; symptoms often localize well in this age group |
| Urinalysis/Urine Culture | Urinary symptoms; fever without source; history of urinary tract infection | Clean catch specimen acceptable in toilet-trained children |
| Influenza/Respiratory Syncytial Virus Testing | Influenza-like illness during influenza season; may guide therapy and infection control | Rapid antigen tests less sensitive; molecular testing (polymerase chain reaction) more accurate |
| Complete Blood Count and Inflammatory Markers | Prolonged fever; ill appearance; suspected serious bacterial infection; concern for malignancy | Not routinely required in well-appearing child with clear viral source |
Investigations for Specific Clinical Scenarios
Suspected Kawasaki Disease (Fever ≥5 Days)
Initial Workup
- Complete blood count: Thrombocytosis (late), anemia, leukocytosis
- Inflammatory markers: Elevated erythrocyte sedimentation rate (>40 mm/hr), C-reactive protein (>30 mg/L)
- Liver function tests: Elevated transaminases, hypoalbuminemia
- Urinalysis: Sterile pyuria
- Echocardiogram: Coronary artery assessment — essential even if criteria incomplete
Supporting Findings
- Hyponatremia
- Elevated gamma-glutamyl transferase
- Thrombocytosis (typically week 2-3; >450,000/μL)
- Anemia for age
- Cerebrospinal fluid pleocytosis (if lumbar puncture performed)
Suspected Bone or Joint Infection
Laboratory Studies
- Complete blood count: Leukocytosis, left shift
- C-reactive protein: Elevated; useful for monitoring response
- Erythrocyte sedimentation rate: Elevated; slower to normalize than C-reactive protein
- Blood culture: Positive in 30-50% of cases
- Joint aspiration: Cell count (typically >50,000 WBC/μL with >90% neutrophils), Gram stain, culture
Imaging Studies
- Plain radiograph: Initial study; may be normal early; look for soft tissue swelling, joint effusion
- Ultrasound: Excellent for detecting joint effusion (especially hip)
- MRI: Most sensitive for osteomyelitis; shows bone marrow edema early
- Bone scan: Alternative if MRI unavailable; helpful for multifocal disease
Suspected Meningitis/Central Nervous System Infection
| Cerebrospinal Fluid Parameter | Normal Values | Bacterial Meningitis | Viral Meningitis |
|---|---|---|---|
| White Blood Cell Count | <5/μL (older children); <20-30/μL (neonates) | >1,000/μL; neutrophil predominance | 10-500/μL; lymphocyte predominance (early may be neutrophils) |
| Protein | <45 mg/dL (older children); <150 mg/dL (neonates) | Elevated (often >100 mg/dL) | Normal to mildly elevated |
| Glucose | >40 mg/dL or >50% serum glucose | Low (<40 mg/dL or <50% serum) | Normal |
| Gram Stain | No organisms | Organisms visible in 60-90% | No organisms |
Additional cerebrospinal fluid studies to consider:
- Bacterial culture: Gold standard for diagnosis
- Herpes simplex virus polymerase chain reaction: Essential in neonates; consider in any encephalitis
- Enterovirus polymerase chain reaction: Most common cause of viral meningitis
- Meningitis/encephalitis polymerase chain reaction panel: Multiplex testing for multiple pathogens
- Latex agglutination/bacterial antigen testing: May be helpful if antibiotics given before lumbar puncture
Fever of Unknown Origin (>14 Days)
Initial Workup
- Complete blood count with differential and smear review
- Comprehensive metabolic panel
- Liver function tests
- Erythrocyte sedimentation rate and C-reactive protein
- Urinalysis and urine culture
- Blood culture (multiple sets)
- Chest radiograph
- Tuberculin skin test or interferon-gamma release assay
- Lactate dehydrogenase, uric acid (malignancy screen)
- Ferritin (elevated in systemic juvenile idiopathic arthritis, malignancy)
Second-Line Workup (If Initial Unrevealing)
- Echocardiogram (endocarditis, Kawasaki disease)
- Abdominal ultrasound or CT (abscess, lymphadenopathy)
- Bone marrow aspiration/biopsy
- Serologies: Epstein-Barr virus, cytomegalovirus, Bartonella, Brucella
- Antinuclear antibody, complement levels
- Immunoglobulin levels
- HIV testing
- Ophthalmologic examination (uveitis)
- PET scan (occult infection, malignancy)
Laboratory Reference Values by Age
| Test | Neonate | Infant/Toddler | Child/Adolescent |
|---|---|---|---|
| White Blood Cell Count (×10³/μL) | 9-30 (higher normal range) | 6-17 | 5-15 |
| Absolute Neutrophil Count (×10³/μL) | 6-26 (nadir at 2 weeks: 1-9) | 1.5-8.5 | 1.8-7.7 |
| Platelet Count (×10³/μL) | 150-400 | 150-400 | 150-400 |
| C-Reactive Protein (mg/L) | <10 (some use <20) | <10 | <10 |
| Procalcitonin (ng/mL) | <0.5 (higher in first 48 hours of life) | <0.5 | <0.5 |
| Cerebrospinal Fluid WBC (/μL) | <20-30 | <5 | <5 |
| Cerebrospinal Fluid Protein (mg/dL) | <150 | <45 | <45 |
Empiric Treatment as Diagnostic Tool
Therapeutic Trials That Aid Diagnosis
In certain clinical scenarios, response to empiric treatment can help confirm suspected diagnoses:
- Single-dose corticosteroid for suspected PFAPA: Dramatic defervescence within hours strongly supports diagnosis; rebound may occur 2-3 days later
- Naproxen test for systemic juvenile idiopathic arthritis: Anti-inflammatory doses of naproxen may dramatically improve fever and systemic symptoms
- Intravenous immunoglobulin for Kawasaki disease: Rapid defervescence within 24-48 hours supports diagnosis; lack of response prompts reconsideration
- Empiric antibiotics for suspected bone/joint infection: Clinical improvement within 48-72 hours supports diagnosis (but obtain cultures first)
When to Obtain Imaging
| Imaging Study | Indications in Febrile Child | Key Findings |
|---|---|---|
| Chest Radiograph | Tachypnea, hypoxia, respiratory distress, abnormal lung examination, prolonged fever without source | Infiltrate, consolidation, effusion, lymphadenopathy |
| Abdominal Ultrasound | Abdominal pain, suspected appendicitis, abscess, pyelonephritis, hepatosplenomegaly | Appendiceal diameter >6 mm, abscess, hydronephrosis, organomegaly |
| Abdominal/Pelvic CT | Suspected appendicitis (if ultrasound non-diagnostic), intra-abdominal abscess, complicated infection | Appendicitis, abscess, lymphadenopathy; use sparingly due to radiation |
| Neck CT with Contrast | Suspected deep neck space infection (retropharyngeal, parapharyngeal abscess) | Ring-enhancing collection, airway deviation, lymphadenopathy |
| Hip Ultrasound | Limp, hip pain, refusal to bear weight | Joint effusion (cannot differentiate septic arthritis from transient synovitis by imaging alone) |
| MRI | Suspected osteomyelitis, discitis, epidural abscess, brain abscess | Bone marrow edema, soft tissue involvement, abscess |
| Echocardiogram | Kawasaki disease, suspected endocarditis, myocarditis | Coronary artery aneurysm/dilation, vegetations, decreased function |
Clinical Pearl: The Role of Viral Testing
Respiratory viral testing (polymerase chain reaction panels) has an increasingly important role in the evaluation of febrile infants. Identification of a viral pathogen (such as respiratory syncytial virus, influenza, or enterovirus) in a well-appearing infant helps with risk stratification — these infants have a lower (though not zero) risk of concurrent serious bacterial infection. Viral testing can support outpatient management in low-risk infants and guide infection control. However, viral identification does not eliminate the need for urine testing, as urinary tract infection can coexist with viral illness, particularly in young infants.
7. Clinical Decision-Making
Practical algorithms and decision pathways for the febrile pediatric patient
Clinical decision-making for the febrile child requires integration of age, clinical appearance, vital signs, physical examination findings, and available diagnostic data. This section provides practical algorithms to guide management from initial triage through disposition decisions.
Step 1: Is This Child Critically Ill?
Before any other considerations, rapidly assess for life-threatening conditions requiring immediate intervention.
| Clinical Scenario | Urgency Level | Immediate Action |
|---|---|---|
| Toxic appearance, signs of shock (poor perfusion, altered mental status, hypotension) | EMERGENT | Airway/Breathing/Circulation; IV access; 20 mL/kg fluid bolus; blood culture; empiric antibiotics immediately; do not delay for testing |
| Petechial/purpuric rash with fever | EMERGENT | Assume meningococcemia; IV antibiotics (ceftriaxone) immediately; resuscitation; isolation; contact public health |
| Severe respiratory distress (apnea, cyanosis, exhaustion, oxygen saturation <90%) | EMERGENT | Oxygen; airway support; prepare for intubation if needed; chest radiograph; consider sepsis |
| Febrile seizure (ongoing or prolonged) | EMERGENT | Benzodiazepine; airway management; check glucose; once controlled, evaluate for meningitis if complex features |
| Bulging fontanelle with fever (infant) | EMERGENT | Assume bacterial meningitis; IV antibiotics immediately; lumbar puncture when stable |
| Febrile neonate (0-28 days) | URGENT | Full sepsis workup; admit; empiric antibiotics (ampicillin + gentamicin or cefotaxime); consider acyclovir if herpes simplex virus risk factors |
| Febrile infant 29-60 days, ill-appearing or high-risk criteria | URGENT | Full workup including lumbar puncture; admit; empiric antibiotics |
| Immunocompromised patient with fever (oncology, transplant, immunodeficiency) | URGENT | Neutropenic fever protocol; cultures; broad-spectrum antibiotics within 60 minutes; contact specialist |
| Fever ≥5 days in child <5 years | URGENT | Evaluate for Kawasaki disease; obtain echocardiogram; do not delay treatment waiting for all criteria |
| Fever with limp/refusal to bear weight | URGENT | Evaluate for septic arthritis/osteomyelitis; labs, imaging; orthopedic consultation |
| Well-appearing febrile child >3 months with clear viral source | ROUTINE | Supportive care; antipyretics for comfort; anticipatory guidance; return precautions |
Step 2: Classify by Age
Age is the single most important factor determining the approach to the febrile child.
0-28 Days
Risk: 8-12% serious bacterial infection
Approach: Full sepsis workup for ALL
Disposition: Admit all; empiric antibiotics
Proceed to Algorithm A
29-90 Days
Risk: 3-10% serious bacterial infection
Approach: Risk stratification
Disposition: Based on risk criteria and clinical appearance
Proceed to Algorithm B
>90 Days
Risk: <3% serious bacterial infection
Approach: Clinical assessment; source-directed
Disposition: Most can be managed as outpatients
Proceed to Algorithm C
Algorithm A: Febrile Neonate (0-28 Days)
Universal Approach — No Exceptions:
- Obtain complete sepsis workup: complete blood count, blood culture, urinalysis/culture (catheterized), lumbar puncture with cerebrospinal fluid studies
- Consider herpes simplex virus testing (cerebrospinal fluid polymerase chain reaction, surface cultures) if any risk factors: maternal herpes simplex virus history, vesicles, seizures, elevated liver enzymes, cerebrospinal fluid pleocytosis
- Obtain chest radiograph if any respiratory symptoms
- Admit to hospital
- Start empiric antibiotics: Ampicillin PLUS Gentamicin (or Cefotaxime)
- Add Acyclovir if herpes simplex virus suspected or cannot be excluded
- Continue antibiotics pending culture results (minimum 36-48 hours for blood/cerebrospinal fluid cultures)
| Clinical Scenario | Management | Duration |
|---|---|---|
| Cultures negative at 36-48 hours, well-appearing, normal cerebrospinal fluid | Discontinue antibiotics; discharge with close follow-up | Follow-up within 24 hours |
| Urinary tract infection confirmed | Complete parenteral antibiotics; transition to oral when improving | 10-14 days total; renal ultrasound; consider voiding cystourethrogram |
| Bacteremia without meningitis | Parenteral antibiotics; repeat blood culture to document clearance | 7-10 days depending on organism |
| Bacterial meningitis | Parenteral antibiotics; infectious disease consultation | 14-21 days depending on organism |
| Herpes simplex virus infection | IV acyclovir; infectious disease consultation | 14 days (skin/eye/mouth) to 21 days (central nervous system/disseminated) |
Algorithm B: Febrile Infant (29-90 Days)
| Step | Assessment | Action |
|---|---|---|
| 1 | Is infant ill-appearing or toxic? | YES: Full sepsis workup; admit; empiric antibiotics immediately NO: Proceed to step 2 |
| 2 | Obtain baseline investigations: complete blood count, urinalysis/culture, inflammatory markers (C-reactive protein, procalcitonin) | Consider blood culture, respiratory viral panel |
| 3 | Apply risk stratification criteria (Rochester, Step-by-Step) | HIGH-RISK: Lumbar puncture; admit; empiric antibiotics LOW-RISK: Proceed to step 4 |
| 4 | Low-risk infant: Is urinalysis positive? | YES: Treat urinary tract infection; consider admission for infants 29-60 days; outpatient may be appropriate for 61-90 days if reliable follow-up NO: Proceed to step 5 |
| 5 | Low-risk infant with negative urinalysis: Is positive viral test available? | YES: Supports lower risk; consider observation without antibiotics NO: Lower threshold for lumbar puncture and empiric treatment in 29-60 day group |
| 6 | Disposition decision | ADMIT: Age 29-60 days (most), high-risk criteria, positive urinalysis, parental concern, unreliable follow-up CONSIDER OUTPATIENT: Age 61-90 days, low-risk, negative workup, reliable follow-up within 24 hours |
Low-Risk Criteria Summary (Rochester Criteria)
- Previously healthy term infant
- Well-appearing on examination
- No focal bacterial infection (except otitis media)
- White blood cell count 5,000-15,000/μL
- Absolute band count <1,500/μL
- Urinalysis: <10 white blood cells per high-power field
- If diarrhea present: stool <5 white blood cells per high-power field
Note: Newer criteria incorporate procalcitonin and C-reactive protein for improved risk stratification.
Algorithm C: Febrile Child (>90 Days)
| Clinical Scenario | Most Likely Diagnosis | Management Approach |
|---|---|---|
| Well-appearing, clear viral upper respiratory infection symptoms | Viral upper respiratory infection | Supportive care; antipyretics for comfort; no testing required; return precautions |
| Fever with ear pain, bulging tympanic membrane | Acute otitis media | Antibiotics if meets criteria (age <2 years, bilateral, severe symptoms); observation option for older children with mild disease |
| Fever with sore throat, tonsillar exudate, anterior cervical adenopathy | Pharyngitis (viral or Group A Streptococcus) | Rapid strep test; antibiotics if Group A Streptococcus positive; supportive care if viral |
| Fever with cough, tachypnea, crackles | Pneumonia | Chest radiograph; antibiotics (amoxicillin first-line for community-acquired); assess need for hospitalization |
| Fever without source, well-appearing | Likely viral; consider urinary tract infection | Urinalysis (especially in girls <2 years, uncircumcised boys <1 year); close follow-up; return if fever persists >3-5 days |
| Fever ≥5 days without clear source | Consider Kawasaki disease | Laboratory evaluation (complete blood count, inflammatory markers, liver function tests, urinalysis); echocardiogram; do not delay treatment if clinical suspicion high |
| Fever with limp or joint swelling | Septic arthritis, osteomyelitis, transient synovitis | Laboratory workup; imaging (ultrasound for hip effusion, MRI for suspected osteomyelitis); orthopedic consultation |
| Fever with abdominal pain migrating to right lower quadrant | Appendicitis | Surgical consultation; imaging (ultrasound preferred, CT if needed); NPO status |
“What Do I Do If…” Decision Reference
| Clinical Situation | Immediate Action | Next Steps |
|---|---|---|
| Parent reports fever at home but child is afebrile now | Believe the parent; treat as documented fever | Evaluate based on age and clinical appearance; parental report of fever is valid |
| Infant appears well but is 25 days old with fever | Full sepsis workup regardless of appearance | Admit; empiric antibiotics; neonates cannot be risk-stratified out of workup |
| Child has fever and petechiae limited to face/above nipples | Consider benign causes (coughing, vomiting, tourniquet effect) | If well-appearing and petechiae not progressing, may observe with close follow-up; any concern for illness — full meningococcemia workup |
| Febrile child had simple febrile seizure, now well-appearing | Evaluate for source of fever; lumbar puncture NOT routinely required | Meningitis unlikely if developmentally normal, well-appearing, no meningeal signs, and current on Haemophilus influenzae type b and pneumococcal vaccines |
| Parents gave antipyretic before arrival; temperature now normal | Evaluate based on history of fever | Response to antipyretics does NOT distinguish viral from bacterial infection; proceed with age-appropriate evaluation |
| Febrile child on recent antibiotics for otitis media | Consider treatment failure; partially treated serious bacterial infection | Lower threshold for workup; antibiotics may mask evolving bacterial infection |
| Fever in child who received vaccines 24-48 hours ago | Vaccine reaction possible but should not assume | Evaluate based on age; fever in young infant still requires full workup regardless of recent vaccination |
| Oncology patient with fever, even if low-grade | Treat as neutropenic fever emergency until proven otherwise | Cultures, broad-spectrum antibiotics within 60 minutes; contact oncology team immediately |
| Fever has lasted 5 days in a 3-year-old | Strongly consider Kawasaki disease even if not all criteria present | Laboratory evaluation, echocardiogram; consult if uncertain; early treatment prevents coronary complications |
| Well-appearing infant with positive urinalysis but negative culture at 48 hours | Reassess specimen quality and clinical status | If contaminated specimen likely (bag specimen) and infant well, may observe; if catheterized specimen, positive urinalysis warrants treatment pending final culture |
Criteria for Hospitalization
Admit to Hospital
- All febrile neonates (0-28 days)
- Ill or toxic appearance at any age
- High-risk infant 29-60 days
- Suspected or confirmed serious bacterial infection requiring IV antibiotics
- Signs of sepsis or shock
- Suspected meningitis
- Kawasaki disease
- Immunocompromised with fever
- Significant dehydration not correctable with oral fluids
- Respiratory distress requiring oxygen
- Unreliable follow-up or significant parental concern
- Need for diagnostic procedures (joint aspiration, etc.)
May Manage as Outpatient
- Well-appearing child >90 days with clear viral source
- Low-risk infant 61-90 days with negative workup and reliable follow-up
- Uncomplicated otitis media
- Uncomplicated pharyngitis
- Uncomplicated urinary tract infection in older child tolerating oral fluids
- Mild pneumonia in older child without hypoxia
- Reliable caregivers who understand return precautions
- Access to follow-up within 24-48 hours
When to Involve Pediatric Subspecialists
| Subspecialty | When to Consult |
|---|---|
| Pediatric Infectious Disease | Fever of unknown origin; complex or unusual infections; immunocompromised host; neonatal herpes simplex virus; endocarditis; osteomyelitis/septic arthritis; interpretation of atypical cerebrospinal fluid findings |
| Pediatric Cardiology | Kawasaki disease (echocardiogram interpretation, treatment decisions); suspected myocarditis or endocarditis |
| Pediatric Rheumatology | Suspected systemic juvenile idiopathic arthritis; periodic fever syndromes; lupus; vasculitis |
| Pediatric Hematology/Oncology | Suspected malignancy; pancytopenia; febrile neutropenia; macrophage activation syndrome |
| Pediatric Surgery / Orthopedics | Appendicitis; abscess requiring drainage; septic arthritis (joint aspiration/washout); osteomyelitis |
| Pediatric ENT | Deep neck space infection; peritonsillar abscess; mastoiditis; complicated sinusitis |
| Pediatric Intensive Care | Septic shock; respiratory failure; meningococcemia; need for vasoactive support |
Troubleshooting: The Child Who Is Not Improving
Fever Persisting Despite Appropriate Treatment — Ask These Questions
- Is the antibiotic appropriate? — Correct spectrum, dose, route, and duration for the diagnosed infection?
- Is there an undrained collection? — Abscess, empyema, septic joint requiring drainage?
- Is the diagnosis correct? — Reconsider differential; could this be Kawasaki disease, malignancy, or inflammatory condition?
- Is there a resistant organism? — Review culture sensitivities; consider methicillin-resistant Staphylococcus aureus or drug-resistant pathogens
- Is there a drug fever? — Temporal relationship with antibiotics; patient often appears “well for degree of fever”
- Are there multiple foci of infection? — Metastatic infection, endocarditis with emboli?
- Is there an underlying immunodeficiency? — Consider if recurrent or unusual infections
- Is compliance adequate? — Is medication being given correctly? Tolerating oral medications?
Discharge Instructions and Return Precautions
Essential Return Precautions for Parents:
Instruct parents to return immediately or seek emergency care if the child develops any of the following:
- Difficult to wake or unusually sleepy
- Not drinking fluids or not urinating (no wet diapers for 8+ hours)
- Difficulty breathing or breathing very fast
- New rash, especially if it does not fade when pressed
- Severe headache or neck stiffness
- Persistent vomiting
- Seizure
- Fever persisting beyond 3-5 days or getting higher
- Fever returning after being gone for more than 24 hours
- Parent “gut feeling” that something is seriously wrong
8. Clinical Pearls and Pitfalls
Practical wisdom — learn from successes and avoid common mistakes
Must-Know Clinical Pearls
Critical Pitfalls to Avoid
Key Takeaways
- Age stratification is fundamental: The approach to fever differs dramatically between neonates, young infants, and older children. Know the age cutoffs and their implications.
- All febrile neonates (0-28 days) require full sepsis workup and admission: There are no low-risk neonates — clinical appearance cannot be trusted to exclude serious bacterial infection in this age group.
- Urinary tract infection is the most common serious bacterial infection in young febrile infants: Check catheterized urinalysis in all febrile infants without clear source, as urinary tract infection may be present without localizing symptoms.
- Fever ≥5 days in a child under 5 years should prompt consideration of Kawasaki disease: Early treatment prevents coronary artery complications. Do not wait for complete criteria.
- Petechial rash with fever requires urgent evaluation: Petechiae below the nipple line is meningococcemia until proven otherwise. Give antibiotics immediately if suspected.
- Clinical appearance is the most important prognostic factor in older children: A well-appearing child with high fever is generally reassuring, but this assessment is less reliable in infants under 3 months.
- Antipyretics provide comfort but do not alter disease course or reliably distinguish viral from bacterial: Do not use antipyretic response for risk stratification.
- Vaccination status matters: Fully vaccinated children are at much lower risk for invasive pneumococcal and Haemophilus influenzae type b disease compared to the pre-vaccine era.
- Always check immunization status and consider immunodeficiency: Unvaccinated children and those with recurrent or unusual infections need more aggressive evaluation.
- Trust parental instinct: Parents who say their child is “different” or “not acting right” should be taken seriously, as parental concern is an independent predictor of serious illness.
- Document clear return precautions: Ensure families know when to return and have access to follow-up care.
- When in doubt, err on the side of caution: The consequences of missing a serious bacterial infection far outweigh the inconvenience of additional testing or a short hospital stay for observation.
Quick Reference Algorithm
Systematic Approach to the Febrile Child:
- Assess stability: Is this child critically ill? If yes → immediate resuscitation and empiric treatment
- Determine age: The approach fundamentally changes based on age (0-28 days, 29-60 days, 61-90 days, >90 days)
- Assess clinical appearance: Well-appearing versus ill-appearing (less reliable in infants <3 months)
- Search for a source: Complete history and physical examination; identify localizing signs
- Obtain appropriate investigations: Age-guided; urinalysis in young infants; lumbar puncture if indicated
- Apply risk stratification: Use validated criteria (Rochester, Step-by-Step) for infants 29-60 days
- Consider dangerous diagnoses: Meningitis, Kawasaki disease (≥5 days), septic arthritis (limp), meningococcemia (petechiae)
- Decide disposition: Admit if high-risk, ill-appearing, or requires IV treatment; outpatient if low-risk with reliable follow-up
- Provide clear return precautions: Educate parents on warning signs requiring immediate return
- Arrange follow-up: All febrile infants managed as outpatients need follow-up within 24-48 hours
Age-Based Quick Reference Summary
| Age | Risk Level | Key Actions | Disposition |
|---|---|---|---|
| 0-28 days | HIGH (8-12% SBI) | Full sepsis workup (complete blood count, blood culture, urinalysis/culture, lumbar puncture); consider herpes simplex virus | Admit ALL; empiric antibiotics |
| 29-60 days | MODERATE (5-10% SBI) | Laboratory workup; risk stratification; lumbar puncture if high-risk or ill | Admit most; low-risk may observe with very close follow-up |
| 61-90 days | LOWER (3-5% SBI) | Urinalysis essential; additional tests based on appearance | Low-risk may be outpatient with 24-hour follow-up |
| 3-36 months | LOW (1-3% SBI) | Clinical assessment primary; urinalysis if no source; consider chest radiograph if tachypneic | Outpatient if well-appearing with source; follow-up for fever without source |
| >36 months | VERY LOW (<1% SBI) | Source-directed evaluation | Outpatient for most; admit if ill or unable to tolerate oral intake |